首页> 外文期刊>Molecular medicine reports >Synonymous mutation adenomatous polyposis coli(486s) affects exon splicing and may predispose patients to adenomatous polyposis coli/mutY DNA glycosylase mutation-negative familial adenomatous polyposis
【24h】

Synonymous mutation adenomatous polyposis coli(486s) affects exon splicing and may predispose patients to adenomatous polyposis coli/mutY DNA glycosylase mutation-negative familial adenomatous polyposis

机译:同义突变腺瘤性息肉(486s)影响外显子剪接,并且可以使患者倾向于腺瘤性息肉蛋白Coli /官方DNA糖基酶突变 - 阴性腺瘤菌症

获取原文
获取原文并翻译 | 示例
       

摘要

Familial adenomatous polyposis (FAP) is an autosomal dominant-inherited colorectal cancer. Recent advances in genetics have indicated that the majority of patients with FAP carry germline mutations of the adenomatous polyposis coli (APC) and mutY DNA glycosylase (MUTYH) genes. However, a large subset of families with a history of FAP have undetectable pathogenic alterations, termed APC/MUTYH mutation-negative FAP. To investigate the germline mutations in the APC and MUTYH genes in Chinese patients with FAP, 13 unrelated patients were enrolled. Through genetic sequencing, four known pathogenic alterations (Lys1061LysfsTer2, Glu1309AspfsTer4, Arg283Ter and Ser1196Ter) of APC and two novel disease-associated pathogenic mutations (Tyr152Ter and Ter522Gly) in MUTYH were identified in six individuals. For samples that did not present with pathogenic alterations, the functional effects of missense, synonymous and intronic mutations were analyzed using bioinformatics tools and databases. Bioinformatics prediction suggested that the synonymous mutation Tyr486Tyr in APC (APC(486s)) was likely a disease-causing polymorphism and may have induced the exon skipping of APC. A hybrid mini-gene assay was performed, which confirmed that the synonymous single nucleotide polymorphism APC(486s) induced major splicing defects with skipping of exon 12 in APC. The data of the present study suggested that the synonymous polymorphism APC(486s) was a potential pathogenic alteration that predisposed APC/MUTYH mutation-negative patients to FAP.
机译:家族性腺瘤性息肉蛋白(FAP)是常染色体显性遗传的结直肠癌。遗传学的最新进展表明,大多数FAP患者患有腺瘤性息肉组织(APC)和官方DNA糖基糖基酶(MUTYH)基因的种系突变。然而,具有FAP历史的大型家庭具有未检测到的致病性改变,称为APC / mutyH突变阴性FAP。为了研究中国FAP患者的APC和Mutyh基因中的种系突变,注册了13例无关的患者。通过遗传测序,在六个体中鉴定了APC和两种新的疾病相关的致病突变(Tyr1520ter和Tyr1520ter和Tyr1520ter和Tyr522gly)的四种已知的致病性改变(Lys1061Lysfst2,Glu1309appfst4,Arg28×520℃)。对于不存在致病性改变的样品,使用生物信息学工具和数据库分析了畸形,同义和内肾突变的功能效果。生物信息学预测表明,APC(APC(486s))中的同义突变Tyr486Ty可能是疾病导致多态性,并且可能诱导APC的外显子跳跃。进行杂种迷你基因测定,证实同义单核苷酸多态性APC(486s)诱导具有在APC中跳过外显子12的主要剪接缺陷。本研究的数据表明,同义多态性APC(486s)是潜在的致病性改变,即倾向于APC / Mutyh突变阴性患者FAP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号